A Torque on the TORCs
New Study Teases Out mTOR's Roles in Aging and Metabolism
By Anette Breindl
Monday, April 2, 2012
Rapamycin is a decades-old drug, but it is still learning or rather, still teaching scientists new tricks. This week, researchers reported new insights into how the drug affects aging and metabolism and most saliently, that its effects on the two can be separated.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.